195 related articles for article (PubMed ID: 22610724)
1. The detection of heterozygous familial hypercholesterolemia in Ireland.
O'Kane MJ; Menown IB; Graham I; Maher V; Tomkin G; Nicholls P; Graham C
Adv Ther; 2012 May; 29(5):456-63. PubMed ID: 22610724
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
Vishwanath R; Hemphill LC
J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
[TBL] [Abstract][Full Text] [Related]
4. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
[TBL] [Abstract][Full Text] [Related]
5. Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors.
Arca M
Atherosclerosis; 2017 Jan; 256():134-145. PubMed ID: 27993383
[TBL] [Abstract][Full Text] [Related]
6. [Heterozygous familial hypercholesterolemia].
Özcan ÖU; Güleç S
Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():10-8. PubMed ID: 25693359
[TBL] [Abstract][Full Text] [Related]
7. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
Sinan ÜY; Sansoy V
Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
[TBL] [Abstract][Full Text] [Related]
8. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
Bourbon M; Rato Q;
Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
[TBL] [Abstract][Full Text] [Related]
9. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
[TBL] [Abstract][Full Text] [Related]
10. Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemia.
Cao YX; Zhou BY; Sun D; Li S; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Liu G; Dong Q; Li JJ
Per Med; 2019 Nov; 16(6):467-478. PubMed ID: 31691639
[No Abstract] [Full Text] [Related]
11. Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
Singh S; Bittner V
Curr Atheroscler Rep; 2015; 17(2):482. PubMed ID: 25612857
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous familial hypercholesterolemia: prevalence and control rates.
Polychronopoulos G; Tzavelas M; Tziomalos K
Expert Rev Endocrinol Metab; 2021 Jul; 16(4):175-179. PubMed ID: 33993819
[No Abstract] [Full Text] [Related]
13. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle.
Shek A; Alieva R; Kurbanov R; Hoshimov S; Nizamov U; Abdullaeva G; Nagay A
Atherosclerosis; 2018 Oct; 277():524-529. PubMed ID: 30270094
[TBL] [Abstract][Full Text] [Related]
14. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
Austin MA; Hutter CM; Zimmern RL; Humphries SE
Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
[TBL] [Abstract][Full Text] [Related]
15. Screening for familial hypercholesterolaemia.
Bender R; Bell DA; Hooper AJ; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
Pathology; 2012 Feb; 44(2):122-8. PubMed ID: 22228254
[TBL] [Abstract][Full Text] [Related]
16. Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects.
Jannes CE; Santos RD; de Souza Silva PR; Turolla L; Gagliardi AC; Marsiglia JD; Chacra AP; Miname MH; Rocha VZ; Filho WS; Krieger JE; Pereira AC
Atherosclerosis; 2015 Jan; 238(1):101-7. PubMed ID: 25461735
[TBL] [Abstract][Full Text] [Related]
17. [Heterozygous familial hypercholesterolemia: the first challenge for anti-PCSK9 monoclonal antibodies].
Zambon A
G Ital Cardiol (Rome); 2016 Apr; 17(4 Suppl 1):22S-30. PubMed ID: 27312020
[TBL] [Abstract][Full Text] [Related]
18. Association between lipoprotein (a) and proprotein convertase substilisin/kexin type 9 in patients with heterozygous familial hypercholesterolemia: A case-control study.
Sun D; Li S; Zhao X; Wu NQ; Zhu CG; Guo YL; Gao Y; Qing P; Cui CJ; Liu G; Sun J; Dong Q; Li JJ
Metabolism; 2018 Feb; 79():33-41. PubMed ID: 29129821
[TBL] [Abstract][Full Text] [Related]
19. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
20. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
